WallStreetZenWallStreetZen

NASDAQ: BGMS
Bio Green Med Solution Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BGMS stock forecasts and price targets.

Forecast return on equity

Is BGMS forecast to generate an efficient return?

Company
258.5%
Industry
90.93%
Market
339.41%
BGMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BGMS forecast to generate an efficient return on assets?

Company
224.85%
Industry
27.18%
BGMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BGMS earnings per share forecast

What is BGMS's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.14
Avg 2 year Forecast
$3.74

BGMS revenue forecast

What is BGMS's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$102.0k+25.93%
Avg 2 year Forecast
$82.2M+101,374.07%
BGMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BGMS revenue growth forecast

How is BGMS forecast to perform vs Biotechnology companies and vs the US market?

Company
25.93%
Industry
11,327.21%
Market
1,459.76%
BGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BGMS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BGMS$1.37N/AN/A
LYRA$3.77$16.00+324.74%Hold
SLXN$2.12$6.00+183.02%Strong Buy
DWTX$2.85$12.00+321.05%Buy
KTTA$0.93$3.00+222.23%Buy
View Top Biotech Stocks

Bio Green Med Solution Stock Forecast FAQ

What is BGMS's earnings growth forecast for 2026-2027?

(NASDAQ: BGMS) Bio Green Med Solution's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 211.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,144.89%.

Bio Green Med Solution's earnings in 2026 is -$6,974,000.On average, 3 Wall Street analysts forecast BGMS's earnings for 2026 to be -$5,597,922, with the lowest BGMS earnings forecast at -$5,378,396, and the highest BGMS earnings forecast at -$5,762,567.

In 2027, BGMS is forecast to generate $18,343,192 in earnings, with the lowest earnings forecast at $17,623,851 and the highest earnings forecast at $18,882,697.

If you're new to stock investing, here's how to buy Bio Green Med Solution stock.

What is BGMS's revenue growth forecast for 2026-2027?

(NASDAQ: BGMS) Bio Green Med Solution's forecast annual revenue growth rate of 25.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11,327.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,459.76%.

Bio Green Med Solution's revenue in 2026 is $81,000.On average, 3 Wall Street analysts forecast BGMS's revenue for 2026 to be $499,814, with the lowest BGMS revenue forecast at $480,214, and the highest BGMS revenue forecast at $514,515.

In 2027, BGMS is forecast to generate $402,762,272 in revenue, with the lowest revenue forecast at $386,964,214 and the highest revenue forecast at $414,605,915.

What is BGMS's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: BGMS) forecast ROA is 224.85%, which is higher than the forecast US Biotechnology industry average of 27.18%.

What is BGMS's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: BGMS) Bio Green Med Solution's current Earnings Per Share (EPS) is -$14.29. On average, analysts forecast that BGMS's EPS will be -$1.14 for 2026, with the lowest EPS forecast at -$1.10, and the highest EPS forecast at -$1.18. In 2027, BGMS's EPS is forecast to hit $3.74 (min: $3.60, max: $3.85).

What is BGMS's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: BGMS) forecast ROE is 258.5%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.